TKNO
Alpha Teknova IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$151.65M
P/E Ratio
—
EPS
$-0.31
Beta
0.33
52W High
$7.48
52W Low
$1.91
50-Day MA
$2.55
200-Day MA
$4.18
Dividend Yield
—
Profit Margin
-42.60%
Forward P/E
—
PEG Ratio
—
About Alpha Teknova Inc
Alpha Teknova Inc (TKNO) is a leading provider of synthetic biology solutions, specializing in high-quality biological reagents and supplements essential for life sciences research and biomanufacturing. The company addresses critical needs across key sectors, such as vaccine development, cell and gene therapy, and diagnostic testing, while maintaining a steadfast commitment to quality and customer service excellence. With a robust foundation in biotechnology and a focus on innovation, Alpha Teknova is well-positioned to capitalize on the expanding opportunities within the life sciences market, fostering growth and delivering value to its investors.
Fundamentals
| Revenue (TTM) | $40.52M |
| Gross Profit (TTM) | $13.44M |
| EBITDA | $-10.13M |
| Operating Margin | -41.20% |
| Return on Equity | -22.80% |
| Return on Assets | -9.26% |
| Revenue/Share (TTM) | $0.76 |
| Book Value | $1.28 |
| Price-to-Book | 2.46 |
| Price-to-Sales (TTM) | 3.74 |
| EV/Revenue | 4.35 |
| EV/EBITDA | -6.23 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 7.80% |
| Shares Outstanding | $53.59M |
| Float | $10.33M |
| % Insiders | 10.80% |
| % Institutions | 83.62% |
Historical Volatility
HV 10-Day
83.59%
HV 20-Day
74.94%
HV 30-Day
96.42%
HV 60-Day
87.80%
HV Rank
90.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($9.00 target)
4
Buy2
HoldData last updated: 4/9/2026